Etiket: Novartis
Roche shares, Novartis shares: Roche and Novartis are likely to distribute allergy drug Xolair in the USA
The US Food and Drug Administration (FDA) has approved the drug Xolair from Novartis and Roche to reduce allergic reactions after contact with food. As the pharmaceutical companies Roche and…
Novartis wants to swallow Morphosys
BASEL (dpa-AFX) – The Swiss pharmaceutical company Novartis wants to take over the biotech company MorphoSys. Morphosys shareholders will be offered 68 euros per share, Novartis and Morphosys announced on…
Insider – Novartis wants to take over biotech company Morphosys
New York (Reuters) – According to insiders, the Swiss pharmaceutical company Novartis is in advanced talks to take over the biotech company Morphosys. Novartis prevailed against the drug manufacturer Incyte,…
Novartis Stock: Novartis loses in US patent litigation
The Swiss pharmaceutical company Novartis has lost a lawsuit in the USA over a patent for its heart drug Entresto. The US District Court for the District of Delaware has…
Equities in Switzerland close more easily – Novartis under pressure
ZURICH (Dow Jones) — The stock market in Switzerland ended Monday lighter. This ended the two-day winning streak from the previous week and the market resumed its overall downward movement.…
Novartis shares: Greek ex-vice minister fined in Novartis scandal
A former deputy justice minister in Greece has been fined 10,000 euros for dealing with the corruption scandal involving the pharmaceutical company Novartis. ttn-28
Novartis Stock: Novartis presents positive long-term data for Cosentyx
The pharmaceutical company Novartis has presented long-term data on the drug Cosentyx (secukinumab) in use against the skin disease hidradenitis suppurativa (HS). ttn-28
Novartis shares make profits: Novartis launches Sandoz generics division – IPO planned for 2023
The IPO is planned for the second half of 2023, Novartis announced on Thursday. Sandoz includes Novartis’ biosimilars and over-the-counter medicines businesses. Novartis announced in October 2021 that it would…
Greece demands 214 million euros from Novartis for allegedly bribing doctors
Greece is demanding 214 million euros in damages with interest from the Swiss pharmaceutical company Novartis, over a suspected corruption scandal. Novartis is suspected of selling drugs at exaggerated prices.…
Novartis shares in demand: Novartis has made a solid start to the new year as a whole – forecast confirmed
The pharmaceutical company was able to increase both sales and earnings and has accordingly confirmed its forecast for the year. The Basler’s net sales rose slightly by 1 percent to…